S

Salarius Pharmaceuticals
D

SLRX

1.41000
USD
0.00
(0.00%)
Market Closed
Volume
0
EPS
0
Div Yield
0
P/E
-0
Market Cap
2,032,031
OverviewSignalsIdeasNews
Related Instruments
    ABBV
    4.380
    (2.36%)
    169.65 USD
    BMY
    0.620
    (1.30%)
    48.180 USD
    GILD
    0.470
    (0.62%)
    76.510 USD
    JNJ
    2.930
    (1.86%)
    151.88 USD
    MRK
    0.680
    (0.60%)
    98.34 USD
    PFE
    0.115
    (0.38%)
    26.025 USD
    More
News

Title: Salarius Pharmaceuticals Inc.

Sector: Healthcare
Industry: Biotechnology
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.